Companies/Appili Therapeutics Inc

Company profile

Appili Therapeutics Inc

OTC: APLIF · Healthcare · Medical - Pharmaceuticals

Canadian filerHQ Halifax, NSReports USD

#999 of 1,394 Healthcare companies by revenuetop-quartile growth

EA Score

28D

FH 21DQ —GM 50SS 26

v0.1 · 45/100 weight · provisional

↑ revenue growth (YoY), disclosure history · ↓ balance-sheet leverage, Altman-Z

Methodology →

Revenue TTM

$188.5k

Rev growth YoY (TTM)

+161.3%

Net income (FY)

-$3.1M

Employees

Market cap

$1.5M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$177.1k244.8k CAD2026

Net income-$3.1M-4.3M CAD2026

Operating income-$4.7M-6.6M CAD2026

Total assets$1.4M2.0M CAD2026

Liabilities$13.9M19.4M CAD2026

Equity-$12.5M-17.4M CAD2026

Revenue trend

FY2019 – FY2026 · USD

FY19

$149.6k

FY20

FY21

$1.1M

FY22

$252.7k

FY23

$613.5k

FY24

$72.2k

FY25

$177.1k

FY26

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Appili Therapeutics Inc booked $177.1k in FY2026 revenue, growing 145% year over year — faster than most Healthcare companies we track, at a -1736.7% net margin.

Peers · Healthcare

Somatic Systems, Inc.——Intelligent Bio Solutions Inc.39D Fuse Medical, Inc.——Panacea Life Sciences Holdings, Inc.——

Key facts

CEODon Cilla

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersHalifax, NS

ExchangeOTC: APLIF

Employees7

IPO date2021-01-08

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.